Disease and Therapy Review: Rheumatoid ArthritisTimely Data Resources, Inc.
November 21, 2010
13 Pages - SKU: TDR6000005
Additional InformationDisease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
More Global Rheumatology/Arthritis reports
Global Musculoskeletal Drugs Market 2011-2015 by Infiniti Research Limited
TechNavio’s analysts forecast the Global Musculoskeletal Drugs market to grow at a CAGR of 14.4 percent over the period 2011–2015. One of the key factors ...
Global Rheumatoid Arthritis Drugs Market 2011-2015 by Infiniti Research Limited
TechNavio’s analysts forecast the Global Rheumatoid Arthritis Drugs market to grow at a CAGR of 12.1 percent over the period 2011–2015. One of the key ...
Rheumatoid Arthritis: World Drug Market 2011-2021 by Visiongain
How will the market for rheumatoid arthritis treatments perform from 2011? Visiongain's report shows you potential revenues to 2021, discussing opportunities and prospects. ...
Therapeutics and Biomaterials for Musculoskeletal Disease: Global Markets by BCC ResearchSee all reports like this >>
The global market for musculoskeletal disease is currently approaching $45 billion. The overall 5-year compound annual growth rate (CAGR) is forecasted to be about ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Rheumatoid Arthritis – Pipeline Review, H1 2013
- Rheumatoid Arthritis Partnering 2007-2013
- Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth
- Rheumatoid Arthritis in Brazil, Russia, and China – How Are Payers and Prescribers Promoting or Limiting Growth in the Biologics Markets
- LaunchTrends®: Abatacept SC (Orencia SC) (Wave 4) 2012